{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T05:07:18Z","timestamp":1794632838958,"version":"4.9.1"},"reference-count":220,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFE0109800"],"award-info":[{"award-number":["2023YFE0109800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82020108024"],"award-info":[{"award-number":["82020108024"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ejmech.2025.117527","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T08:59:48Z","timestamp":1742461188000},"page":"117527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Pharmacological advances and therapeutic applications of niclosamide in cancer and other diseases"],"prefix":"10.1016","volume":"290","author":[{"given":"Umm E.","family":"Laila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-long","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Yu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Xiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117527_bib1","first-page":"89","volume":"vol. 41","author":"Chen","year":"2018"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117527_bib2","first-page":"245","volume":"19","author":"Andrews","year":"1982","journal-title":"The biology and toxicology of molluscicides, Bayluscide"},{"key":"10.1016\/j.ejmech.2025.117527_bib3","series-title":"American College of Physicians","first-page":"550","article-title":"Niclosamide therapy for tapeworm infections","author":"Pearson","year":"1985"},{"issue":"5","key":"10.1016\/j.ejmech.2025.117527_bib4","first-page":"1011","article-title":"Niclosamide suppresses macrophage-induced inflammation in endometriosis","volume":"102","author":"Sekulovski","year":"2020"},{"issue":"24","key":"10.1016\/j.ejmech.2025.117527_bib5","article-title":"Niclosamide as a promising therapeutic player in human cancer and other diseases","volume":"23","author":"Wang","year":"2022"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117527_bib6","first-page":"8","article-title":"Multi-targeted therapy of cancer by niclosamide: a new application for an old drug","volume":"349","author":"Li","year":"2014"},{"issue":"9","key":"10.1016\/j.ejmech.2025.117527_bib7","first-page":"3233","article-title":"Mechanisms of multidrug resistance in cancer chemotherapy","volume":"21","author":"Bukowski","year":"2020"},{"key":"10.1016\/j.ejmech.2025.117527_bib8","first-page":"110","volume":"vol. 8","author":"Hamdoun","year":"2017"},{"issue":"4","key":"10.1016\/j.ejmech.2025.117527_bib9","first-page":"178","volume":"31","author":"Pan","year":"2012","journal-title":"Niclosamide, an old antihelminthic agent, demonstrates antitumor activity by blocking multiple signaling pathways of cancer stem cells"},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2025.117527_bib10","first-page":"193","article-title":"Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrins","volume":"304","author":"Devarakonda","year":"2005"},{"issue":"12","key":"10.1016\/j.ejmech.2025.117527_bib11","article-title":"Niclosamide & challenges in chemical modifications: a broad review on enhancement of solubility","volume":"98","author":"Kapale","year":"2021"},{"key":"10.1016\/j.ejmech.2025.117527_bib12","first-page":"58","volume":"vol. 141","author":"Barbosa","year":"2019"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117527_bib13","first-page":"115","article-title":"The pH dependence of niclosamide solubility, dissolution, and morphology: motivation for potentially universal mucin-penetrating nasal and throat sprays for COVID19, its variants and other viral infections","volume":"39","author":"Needham","year":"2022"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117527_bib14","first-page":"417","article-title":"Preparation and physicochemical properties of niclosamide anhydrate and two monohydrates","volume":"269","author":"van Tonder","year":"2004"},{"issue":"6","key":"10.1016\/j.ejmech.2025.117527_bib15","first-page":"581","article-title":"Comparison of the physical and chemical stability of niclosamide crystal forms in aqueous versus nonaqueous suspensions","volume":"30","author":"de Villiers","year":"2004"},{"key":"10.1016\/j.ejmech.2025.117527_bib16","volume":"107","author":"He","year":"2021","journal-title":"Discovery of degradable niclosamide derivatives able to specially inhibit small cell lung cancer (SCLC)"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117527_bib17","first-page":"1","article-title":"Comparative genotoxicity of six salicylic acid derivatives in bone marrow cells of mice","volume":"370","author":"Giri","year":"1996"},{"issue":"11","key":"10.1016\/j.ejmech.2025.117527_bib18","first-page":"1263","article-title":"Niclosamide ethanolamine\u2013induced mild mitochondrial uncoupling improves diabetic symptoms in mice","volume":"20","author":"Tao","year":"2014"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117527_bib19","first-page":"91","article-title":"Niclosamide piperazine prevents high-fat diet-induced obesity and diabetic symptoms in mice","volume":"24","author":"Jingjing","year":"2019"},{"issue":"3","key":"10.1016\/j.ejmech.2025.117527_bib20","first-page":"389","volume":"22","author":"Gemmell","year":"1977","journal-title":"The effect of niclosamide on Echinococcus granulosus, Taenia hydatigena and Taenia ovis infections in dogs"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117527_bib21","first-page":"273","article-title":"The mechanisms of action of antiprotozoal and anthelmintic drugs in man","volume":"28","author":"Frayha","year":"1997"},{"key":"10.1016\/j.ejmech.2025.117527_bib22","series-title":"Mechanisms of Anthelmintic Action","first-page":"147","author":"Sheth","year":"1975"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117527_bib23","first-page":"215","article-title":"Effect of mitochondrial uncouplers niclosamide ethanolamine (NEN) and oxyclozanide on hepatic metastasis of colon cancer","volume":"9","author":"Alasadi","year":"2018"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117527_bib24","first-page":"181","article-title":"Mitochondrial uncoupling induces epigenome remodeling and promotes differentiation in neuroblastoma","volume":"83","author":"Jiang","year":"2023"},{"issue":"8","key":"10.1016\/j.ejmech.2025.117527_bib25","first-page":"2022","article-title":"Computational discovery of niclosamide ethanolamine, a repurposed drug candidate that reduces growth of hepatocellular carcinoma cells in vitro and in mice by inhibiting cell division cycle 37 signaling","volume":"152","author":"Chen","year":"2017"},{"key":"10.1016\/j.ejmech.2025.117527_bib26","first-page":"143","volume":"vol. 137","author":"Park","year":"2019"},{"issue":"3","key":"10.1016\/j.ejmech.2025.117527_bib27","first-page":"346","article-title":"Niclosamide ethanolamine salt alleviates idiopathic pulmonary fibrosis by modulating the PI3K-mTORC1 pathway","volume":"11","author":"Pei","year":"2022"},{"key":"10.1016\/j.ejmech.2025.117527_bib28","series-title":"Biomimetic Nano\u2010Cancer Stem Cell Scavenger for Inhibition of Breast Cancer Recurrence and Metastasis after FLASH\u2010Radiotherapy","author":"Suo","year":"2024"},{"key":"10.1016\/j.ejmech.2025.117527_bib29","first-page":"78","volume":"vol. 115","author":"Li","year":"2017"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117527_bib30","first-page":"10","article-title":"Niclosamide ethanolamine prevents muscle wasting by inhibiting p38 MAPK-FoxO3a activation in mice exposed to doxorubicin","volume":"13","author":"Zhan","year":"2020"},{"key":"10.1016\/j.ejmech.2025.117527_bib31","first-page":"229","volume":"vol. 853","author":"Wei","year":"2019"},{"key":"10.1016\/j.ejmech.2025.117527_bib32","series-title":"Handbook of Pesticide Toxicology","first-page":"1169","article-title":"Inhibitors and uncouplers of mitochondrial oxidative phosphorylation","author":"Hollingworth","year":"2001"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117527_bib33","article-title":"Drug solubility: importance and enhancement techniques","volume":"2012","author":"Savjani","year":"2012"},{"key":"10.1016\/j.ejmech.2025.117527_bib34","first-page":"91","article-title":"Niclosamide piperazine prevents high-fat diet-induced obesity and diabetic symptoms in mice","volume":"24","author":"Guo","year":"2019"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117527_bib35","first-page":"180","article-title":"Discovery of O-alkylamino-tethered niclosamide derivatives as potent and orally bioavailable anticancer agents","volume":"4","author":"Chen","year":"2013"},{"issue":"11","key":"10.1016\/j.ejmech.2025.117527_bib36","first-page":"1399","article-title":"Discovery of niclosamide and its O-alkylamino-tethered derivatives as potent antibacterial agents against carbapenemase-producing and\/or colistin resistant Enterobacteriaceae isolates","volume":"29","author":"Xu","year":"2019"},{"issue":"10","key":"10.1016\/j.ejmech.2025.117527_bib37","first-page":"2616","article-title":"JMX0207, a niclosamide derivative with improved pharmacokinetics, suppresses Zika virus infection both in vitro and in vivo","volume":"6","author":"Li","year":"2020"},{"issue":"3","key":"10.1016\/j.ejmech.2025.117527_bib38","first-page":"326","article-title":"Novel derivatives of niclosamide synthesis: its bioactivity and interaction with Schistosoma japonicum cercariae","volume":"88","author":"Wu","year":"2011"},{"issue":"5","key":"10.1016\/j.ejmech.2025.117527_bib39","article-title":"In silico study of novel niclosamide derivatives, SARS-CoV-2 nonstructural proteins catalytic residue-targeting small molecules drug candidates","volume":"16","author":"Lawal","year":"2023"},{"key":"10.1016\/j.ejmech.2025.117527_bib40","volume":"vol. 253","author":"Li","year":"2023"},{"key":"10.1016\/j.ejmech.2025.117527_bib41","volume":"vol. 218","author":"Wang","year":"2021"},{"issue":"8","key":"10.1016\/j.ejmech.2025.117527_bib42","first-page":"3945","article-title":"A new niclosamide derivatives\u2010B17 can inhibit urological cancers growth through apoptosis\u2010related pathway","volume":"7","author":"Wu","year":"2018"},{"issue":"17","key":"10.1016\/j.ejmech.2025.117527_bib43","first-page":"5829","article-title":"Structure\u2013activity studies of Wnt\/\u03b2-catenin inhibition in the Niclosamide chemotype: identification of derivatives with improved drug exposure","volume":"23","author":"Mook","year":"2015"},{"issue":"11","key":"10.1016\/j.ejmech.2025.117527_bib44","first-page":"2482","article-title":"Oxidative phosphorylation as an emerging target in cancer therapy","volume":"24","author":"Ashton","year":"2018"},{"key":"10.1016\/j.ejmech.2025.117527_bib45","series-title":"Structural Investigations on the Mitochondrial Uncouplers Niclosamide and FCCP","author":"Ng","year":"2024"},{"key":"10.1016\/j.ejmech.2025.117527_bib46","volume":"vol. 12","author":"Jiang","year":"2022"},{"issue":"3","key":"10.1016\/j.ejmech.2025.117527_bib47","first-page":"504","article-title":"Structural requirements of salicylanilides for uncoupling activity in mitochondria: quantitative analysis of structure-uncoupling relationships","volume":"936","author":"Terada","year":"1988"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117527_bib48","first-page":"3931","article-title":"Mitochondrial uncoupling reveals a novel therapeutic opportunity for p53-defective cancers","volume":"9","author":"Kumar","year":"2018"},{"key":"10.1016\/j.ejmech.2025.117527_bib49","first-page":"288","volume":"vol. 124","author":"Gao","year":"2018"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117527_bib50","first-page":"1728","article-title":"Salicylanilides and their anticancer properties","volume":"24","author":"Kauerov\u00e1","year":"2023"},{"issue":"7","key":"10.1016\/j.ejmech.2025.117527_bib51","first-page":"1621","article-title":"Superior anticancer and antifungal activities of new sulfanyl-substituted niclosamide derivatives","volume":"12","author":"Ma","year":"2024"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117527_bib52","first-page":"11","article-title":"WNT signalling pathways as therapeutic targets in cancer","volume":"13","author":"Anastas","year":"2013"},{"issue":"43","key":"10.1016\/j.ejmech.2025.117527_bib53","first-page":"10267","article-title":"The anti-helminthic niclosamide inhibits Wnt\/Frizzled 1 signaling","volume":"48","author":"Chen","year":"2009"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117527_bib54","first-page":"9","article-title":"Defining the role of mTOR in cancer","volume":"12","author":"Guertin","year":"2007"},{"issue":"12","key":"10.1016\/j.ejmech.2025.117527_bib55","first-page":"744","article-title":"mTOR signalling and cellular metabolism are mutual determinants in cancer","volume":"18","author":"Mossmann","year":"2018"},{"issue":"50","key":"10.1016\/j.ejmech.2025.117527_bib56","first-page":"35769","article-title":"Suppression of lysosome function induces autophagy via a feedback down-regulation of MTOR complex 1 (MTORC1) activity","volume":"288","author":"Li","year":"2013"},{"key":"10.1016\/j.ejmech.2025.117527_bib57","volume":"vol. 9","author":"Allen","year":"2021"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117527_bib58","first-page":"20","article-title":"Notch signaling: an emerging therapeutic target for cancer treatment","volume":"369","author":"Yuan","year":"2015"},{"issue":"3","key":"10.1016\/j.ejmech.2025.117527_bib59","first-page":"776","article-title":"Niclosamide inhibits colon cancer progression through downregulation of the Notch pathway and upregulation of the tumor suppressor miR-200 family","volume":"38","author":"Suliman","year":"2016"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117527_bib60","first-page":"82","article-title":"Therapeutically exploiting STAT3 activity in cancer\u2014using tissue repair as a road map","volume":"19","author":"Huynh","year":"2019"},{"issue":"8","key":"10.1016\/j.ejmech.2025.117527_bib61","first-page":"4677","article-title":"Mutational analysis of acute-phase response factor\/Stat3 activation and dimerization","volume":"17","author":"Sasse","year":"1997"},{"issue":"5","key":"10.1016\/j.ejmech.2025.117527_bib62","first-page":"821","article-title":"Interferon activation of the transcription factor Stat 91 involves dimerization through SH2-phosphotyrosyl peptide interactions","volume":"76","author":"Shuai","year":"1994"},{"issue":"9","key":"10.1016\/j.ejmech.2025.117527_bib63","first-page":"454","article-title":"Identification of niclosamide as a new small-molecule inhibitor of the STAT3 signaling pathway","volume":"1","author":"Ren","year":"2010"},{"issue":"10","key":"10.1016\/j.ejmech.2025.117527_bib64","first-page":"e39","volume":"1","author":"Khanim","year":"2011","journal-title":"Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain production"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117527_bib65","first-page":"443","article-title":"Molecular basis of NF-\u03baB signaling","volume":"42","author":"Napetschnig","year":"2013"},{"issue":"23","key":"10.1016\/j.ejmech.2025.117527_bib66","first-page":"11093","article-title":"Nuclear factor-\u03baB, an unappreciated tumor suppressor","volume":"67","author":"Chen","year":"2007"},{"issue":"9","key":"10.1016\/j.ejmech.2025.117527_bib67","first-page":"823","article-title":"NF-\u03baB, an active player in human cancers","volume":"2","author":"Xia","year":"2014"},{"issue":"6","key":"10.1016\/j.ejmech.2025.117527_bib68","first-page":"2516","article-title":"Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-\u03baB pathway and generation of reactive oxygen species","volume":"70","author":"Jin","year":"2010"},{"issue":"8","key":"10.1016\/j.ejmech.2025.117527_bib69","first-page":"1685","article-title":"Niclosamide and its derivative DK\u2010520 inhibit RANKL\u2010induced osteoclastogenesis","volume":"10","author":"Jiao","year":"2020"},{"issue":"16","key":"10.1016\/j.ejmech.2025.117527_bib70","first-page":"12078","article-title":"Bionanotherapeutics: niclosamide encapsulated albumin nanoparticles as a novel drug delivery system for cancer therapy","volume":"5","author":"Bhushan","year":"2015"},{"issue":"46","key":"10.1016\/j.ejmech.2025.117527_bib71","first-page":"26572","article-title":"Niclosamide encapsulated polymeric nanocarriers for targeted cancer therapy","volume":"9","author":"Jain","year":"2019"},{"issue":"11","key":"10.1016\/j.ejmech.2025.117527_bib72","article-title":"Niclosamide loaded biodegradable chitosan nanocargoes: an in vitro study for potential application in cancer therapy","volume":"4","author":"Naqvi","year":"2017"},{"issue":"8","key":"10.1016\/j.ejmech.2025.117527_bib73","first-page":"8993","volume":"7","author":"Lin","year":"2016","journal-title":"Preclinical evaluation of a nanoformulated antihelminthic, niclosamide, in ovarian cancer"},{"key":"10.1016\/j.ejmech.2025.117527_bib74","series-title":"Insight into Preventing Global Dengue Spread: Nanoengineered Niclosamide for Viral Infections","author":"Rejinold","year":"2024"},{"key":"10.1016\/j.ejmech.2025.117527_bib75","series-title":"2016 IEEE 16th International Conference on Nanotechnology","article-title":"Niclosamide loaded cationic solid lipid nanoparticles for treatment of cancer","author":"Jain","year":"2016"},{"issue":"5","key":"10.1016\/j.ejmech.2025.117527_bib76","article-title":"Oral delivery of a host-directed antiviral, niclosamide, as a cholate-coated nanoformulation","volume":"62","author":"Zhai","year":"2023"},{"issue":"5","key":"10.1016\/j.ejmech.2025.117527_bib77","first-page":"486","article-title":"Hydrotalcite\u2013niclosamide nanohybrid as oral formulation towards SARS-CoV-2 viral infections","volume":"14","author":"Choi","year":"2021"},{"issue":"34","key":"10.1016\/j.ejmech.2025.117527_bib78","first-page":"12709","article-title":"Niclosamide-conjugated polypeptide nanoparticles inhibit Wnt signaling and colon cancer growth","volume":"9","author":"Bhattacharyya","year":"2017"},{"key":"10.1016\/j.ejmech.2025.117527_bib79","volume":"vol. 261","author":"Zeyada","year":"2020"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117527_bib80","first-page":"1102","article-title":"Hyperbranched polymer-functionalized magnetic nanoparticle-mediated hyperthermia and niclosamide bimodal therapy of colorectal cancer cells","volume":"6","author":"Ahmad","year":"2019"},{"issue":"11","key":"10.1016\/j.ejmech.2025.117527_bib81","first-page":"7811","article-title":"Mesoporous silica nanoparticle-based combination of niclosamide and doxorubicin: effect of treatment regimens on breast cancer subtypes","volume":"4","author":"Lohiya","year":"2021"},{"key":"10.1016\/j.ejmech.2025.117527_bib82","first-page":"1","volume":"vol. 27","author":"Rs","year":"2020"},{"issue":"10","key":"10.1016\/j.ejmech.2025.117527_bib83","first-page":"939","article-title":"Prefused lysosomes cluster on autophagosomes regulated by VAMP8","volume":"12","author":"Chen","year":"2021"},{"key":"10.1016\/j.ejmech.2025.117527_bib84","volume":"vol. 25","author":"Yu","year":"2024"},{"key":"10.1016\/j.ejmech.2025.117527_bib85","series-title":"Combination of Niclosamide with Immunogenic Cell Death-Inducer Delivered by Nanoparticles for Breast Cancer Therapy by Disturbing Pro-survival Autophagy and Efferocytosis","author":"Sun","year":"2024"},{"key":"10.1016\/j.ejmech.2025.117527_bib86","volume":"vol. 605","author":"Jannu","year":"2021"},{"issue":"3","key":"10.1016\/j.ejmech.2025.117527_bib87","first-page":"1405","article-title":"Antihelminthic niclosamide induces autophagy and delayed apoptosis in human non-small lung cancer cells in vitro and in vivo","volume":"40","author":"Chai","year":"2020"},{"issue":"3","key":"10.1016\/j.ejmech.2025.117527_bib88","first-page":"606","article-title":"Disruption of STAT3 by niclosamide reverses radioresistance of human lung cancer","volume":"13","author":"You","year":"2014"},{"issue":"5","key":"10.1016\/j.ejmech.2025.117527_bib89","first-page":"619","article-title":"Niclosamide enhances ROS-mediated cell death through c-Jun activation","volume":"68","author":"Son","year":"2014"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117527_bib90","first-page":"1933","article-title":"Niclosamide enhances the antitumor effects of radiation by inhibiting the hypoxia-inducible factor-1\u03b1\/vascular endothelial growth factor signal","volume":"14","author":"Xiang","year":"2017"},{"key":"10.1016\/j.ejmech.2025.117527_bib91","first-page":"78","volume":"144","author":"Kim","year":"2017","journal-title":"Antihelminthic drug niclosamide inhibits CIP2A and reactivates tumor suppressor protein phosphatase 2A in non-small cell lung cancer cells"},{"issue":"23","key":"10.1016\/j.ejmech.2025.117527_bib92","article-title":"S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamide","volume":"7","author":"Stewart","year":"2016"},{"issue":"10","key":"10.1016\/j.ejmech.2025.117527_bib93","first-page":"2200","volume":"12","author":"Li","year":"2013","journal-title":"Niclosamide overcomes acquired resistance to erlotinib through suppression of STAT3 in non\u2013small cell lung cancer"},{"key":"10.1016\/j.ejmech.2025.117527_bib94","first-page":"1","article-title":"Niclosamide, an antihelmintic drug, enhances efficacy of PD-1\/PD-L1 immune checkpoint blockade in non-small cell lung cancer","volume":"7","author":"Luo","year":"2019"},{"issue":"3","key":"10.1016\/j.ejmech.2025.117527_bib95","first-page":"3497","article-title":"Niclosamide enhances the cytotoxic effect of cisplatin in cisplatin-resistant human lung cancer cells via suppression of lung resistance-related protein and c-myc","volume":"17","author":"Zuo","year":"2018"},{"issue":"8","key":"10.1016\/j.ejmech.2025.117527_bib96","first-page":"1203","article-title":"Targeting the epithelial\u2013mesenchymal transition (EMT) pathway with combination of Wnt inhibitor and chalcone complexes in lung cancer cells","volume":"124","author":"Erturk","year":"2023"},{"issue":"13","key":"10.1016\/j.ejmech.2025.117527_bib97","first-page":"1018","article-title":"Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer","volume":"103","author":"Sack","year":"2011"},{"key":"10.1016\/j.ejmech.2025.117527_bib98","series-title":"Niclosamide Inhibition of STAT3 Synergizes with Erlotinib in Human Colon Cancer","first-page":"1767","author":"Shi","year":"2017"},{"issue":"107","key":"10.1016\/j.ejmech.2025.117527_bib99","first-page":"106019","article-title":"Niclosamide induces colorectal cancer apoptosis, impairs metastasis and reduces immunosuppressive cells in vivo","volume":"6","author":"Yang","year":"2016"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117527_bib100","first-page":"300","article-title":"Niclosamide inhibits oxaliplatin neurotoxicity while improving colorectal cancer therapeutic response","volume":"16","author":"Cerles","year":"2017"},{"issue":"3","key":"10.1016\/j.ejmech.2025.117527_bib101","first-page":"535","article-title":"Niclosamide-induced Wnt signaling inhibition in colorectal cancer is mediated by autophagy","volume":"476","author":"Wang","year":"2019"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117527_bib102","first-page":"193","article-title":"The anthelmintic niclosamide inhibits colorectal cancer cell lines via modulation of the canonical and noncanonical Wnt signaling pathway","volume":"203","author":"Monin","year":"2016"},{"issue":"12","key":"10.1016\/j.ejmech.2025.117527_bib103","first-page":"1633","article-title":"Inhibition of DNA double-strand break repair by niclosamide in human colorectal cancer cells","volume":"46","author":"Zhirnik","year":"2019"},{"issue":"3","key":"10.1016\/j.ejmech.2025.117527_bib104","first-page":"245","article-title":"Evaluation of the anti-tumor activity of niclosamide nanoliposomes against colon carcinoma","volume":"13","author":"Hatamipour","year":"2020"},{"issue":"4","key":"10.1016\/j.ejmech.2025.117527_bib105","first-page":"835","article-title":"Niclosamide induces miR-148a to inhibit PXR and sensitize colon cancer stem cells to chemotherapy","volume":"17","author":"Bansard","year":"2022"},{"issue":"14","key":"10.1016\/j.ejmech.2025.117527_bib106","first-page":"3437","article-title":"Metformin and niclosamide synergistically suppress Wnt and YAP in APC-mutated colorectal cancer","volume":"13","author":"Kang","year":"2021"},{"issue":"10","key":"10.1016\/j.ejmech.2025.117527_bib107","first-page":"1482","article-title":"An integrated bioinformatics analysis repurposes an antihelminthic drug niclosamide for treating HMGA2-overexpressing human colorectal cancer","volume":"11","author":"Leung","year":"2019"},{"issue":"11","key":"10.1016\/j.ejmech.2025.117527_bib108","first-page":"951","article-title":"Impact of oncogenic changes in p53 and KRAS on macropinocytosis and ferroptosis in colon cancer cells and anticancer efficacy of niclosamide with differential effects on these two processes","volume":"13","author":"Nguyen","year":"2024"},{"issue":"19","key":"10.1016\/j.ejmech.2025.117527_bib109","article-title":"Anti-helminthic niclosamide inhibits Ras-driven oncogenic transformation via activation of GSK-3","volume":"8","author":"Ahn","year":"2017"},{"key":"10.1016\/j.ejmech.2025.117527_bib110","first-page":"471","volume":"50","author":"Zhirnik","year":"2016","journal-title":"Antiproliferative Activity of Niclosamide Against Melanoma and Colorectal Cancer Cells"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117527_bib111","first-page":"846","article-title":"Effect of niclosamide on colorectal cancer induced by dimethylhydrazine in albino mice","volume":"10","author":"Sayed","year":"2023"},{"issue":"12","key":"10.1016\/j.ejmech.2025.117527_bib112","article-title":"Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt\/\u03b2-catenin pathway","volume":"6","author":"Lu","year":"2011"},{"issue":"3","key":"10.1016\/j.ejmech.2025.117527_bib113","first-page":"291","article-title":"Induction of oxidative stress and ferroptosis in triple-negative breast cancer cells by niclosamide via blockade of the function and expression of SLC38A5 and SLC7A11","volume":"13","author":"Mathew","year":"2024"},{"issue":"9","key":"10.1016\/j.ejmech.2025.117527_bib114","article-title":"Drug screening identifies niclosamide as an inhibitor of breast cancer stem-like cells","volume":"8","author":"Wang","year":"2013"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117527_bib115","article-title":"The anthelmintic drug niclosamide induces apoptosis, impairs metastasis and reduces immunosuppressive cells in breast cancer model","volume":"9","author":"Ye","year":"2014"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117527_bib116","article-title":"Niclosamide reverses adipocyte induced epithelial-mesenchymal transition in breast cancer cells via suppression of the interleukin-6\/STAT3 signalling axis","volume":"9","author":"Gyamfi","year":"2019"},{"issue":"21","key":"10.1016\/j.ejmech.2025.117527_bib117","article-title":"A dual-action niclosamide-based prodrug that targets cancer stem cells and inhibits TNBC metastasis","volume":"120","author":"Kim","year":"2023"},{"issue":"19","key":"10.1016\/j.ejmech.2025.117527_bib118","article-title":"Selectively targeting breast cancer stem cells by 8-Quinolinol and Niclosamide","volume":"23","author":"C\u00e1mara-S\u00e1nchez","year":"2022"},{"key":"10.1016\/j.ejmech.2025.117527_bib119","first-page":"12","article-title":"Niclosamide inhibits epithelial-mesenchymal transition and tumor growth in lapatinib-resistant human epidermal growth factor receptor 2-positive breast cancer","volume":"71","author":"Liu","year":"2016"},{"issue":"3","key":"10.1016\/j.ejmech.2025.117527_bib120","first-page":"1","article-title":"Anthelminthic niclosamide inhibits tumor growth and invasion in cisplatin-resistant human epidermal growth factor receptor 2-positive breast cancer","volume":"22","author":"Liu","year":"2021"},{"issue":"4","key":"10.1016\/j.ejmech.2025.117527_bib121","first-page":"800","article-title":"Effect of niclosamide on basal-like breast cancers","volume":"13","author":"Londo\u00f1o-Joshi","year":"2014"},{"key":"10.1016\/j.ejmech.2025.117527_bib122","first-page":"1359","volume":"vol. 55","author":"Ramos","year":"2024"},{"issue":"13","key":"10.1016\/j.ejmech.2025.117527_bib123","first-page":"3299","article-title":"A synergistic combination of niclosamide and doxorubicin as an efficacious therapy for all clinical subtypes of breast cancer","volume":"13","author":"Lohiya","year":"2021"},{"issue":"39","key":"10.1016\/j.ejmech.2025.117527_bib124","first-page":"5292","article-title":"Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide","volume":"37","author":"Lu","year":"2018"},{"key":"10.1016\/j.ejmech.2025.117527_bib125","volume":"vol. 167","author":"Zhao","year":"2021"},{"issue":"16","key":"10.1016\/j.ejmech.2025.117527_bib126","first-page":"1551","volume":"15","author":"Ss Pindiprolu","year":"2020","journal-title":"Phenyl boronic acid-modified lipid nanocarriers of niclosamide for targeting triple-negative breast cancer"},{"issue":"17","key":"10.1016\/j.ejmech.2025.117527_bib127","first-page":"5580","volume":"23","author":"Karakas","year":"2015","journal-title":"Addition of niclosamide to palladium (II) saccharinate complex of terpyridine results in enhanced cytotoxic activity inducing apoptosis on cancer stem cells of breast cancer"},{"issue":"29","key":"10.1016\/j.ejmech.2025.117527_bib128","first-page":"7463","article-title":"Anticancer potential of albumin bound Wnt\/\u03b2\u2010catenin pathway inhibitor niclosamide in breast cancer cells","volume":"6","author":"Ari","year":"2021"},{"key":"10.1016\/j.ejmech.2025.117527_bib129","volume":"vol. 316","author":"Mansour","year":"2023"},{"issue":"12","key":"10.1016\/j.ejmech.2025.117527_bib130","first-page":"3454","article-title":"Niclosamide inhibits ovarian carcinoma growth by interrupting cellular bioenergetics","volume":"11","author":"Shangguan","year":"2020"},{"issue":"26","key":"10.1016\/j.ejmech.2025.117527_bib131","first-page":"3452","article-title":"WNT7A\/\u03b2-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer","volume":"34","author":"King","year":"2015"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117527_bib132","first-page":"112","article-title":"Inhibition of Wnt\/\u03b2-catenin pathway by niclosamide: a therapeutic target for ovarian cancer","volume":"134","author":"Arend","year":"2014"},{"issue":"3","key":"10.1016\/j.ejmech.2025.117527_bib133","first-page":"871","article-title":"A blockade of IGF signaling sensitizes human ovarian cancer cells to the anthelmintic niclosamide-induced anti-proliferative and anticancer activities","volume":"39","author":"Deng","year":"2016"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117527_bib134","first-page":"403","article-title":"Niclosamide's potential direct targets in ovarian cancer","volume":"105","author":"Sekulovski","year":"2021"},{"issue":"52","key":"10.1016\/j.ejmech.2025.117527_bib135","volume":"7","author":"Arend","year":"2016","journal-title":"Niclosamide and its analogs are potent inhibitors of Wnt\/\u03b2-catenin, mTOR and STAT3 signaling in ovarian cancer"},{"issue":"4","key":"10.1016\/j.ejmech.2025.117527_bib136","first-page":"1687","article-title":"Niclosamide (NA) overcomes cisplatin resistance in human ovarian cancer","volume":"10","author":"Huang","year":"2023"},{"issue":"8","key":"10.1016\/j.ejmech.2025.117527_bib137","first-page":"1703","article-title":"Growth inhibition of ovarian tumor\u2013initiating cells by niclosamide","volume":"11","author":"Yo","year":"2012"},{"issue":"19_Supplement","key":"10.1016\/j.ejmech.2025.117527_bib138","first-page":"2517","article-title":"STAT3 inhibition by LLL12 in combination with niclosamide and chemotherapy in ovarian cancer","volume":"74","author":"Arend","year":"2014"},{"key":"10.1016\/j.ejmech.2025.117527_bib139","first-page":"248","volume":"vol. 419","author":"Bai","year":"2013"},{"key":"10.1016\/j.ejmech.2025.117527_bib140","volume":"vol. 169","author":"Zhu","year":"2019"},{"issue":"6","key":"10.1016\/j.ejmech.2025.117527_bib141","first-page":"1447","article-title":"The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo","volume":"7","author":"Zhou","year":"2017"},{"key":"10.1016\/j.ejmech.2025.117527_bib142","article-title":"Niclosamide inhibits epithelial-mesenchymal transition with apoptosis induction in BRAF\/NRAS mutated metastatic melanoma cells","volume":"89","author":"Thatikonda","year":"2023"},{"key":"10.1016\/j.ejmech.2025.117527_bib143","volume":"vol. 163","author":"Li","year":"2023"},{"issue":"97","key":"10.1016\/j.ejmech.2025.117527_bib144","article-title":"Bioenergetic modulation with the mitochondria uncouplers SR4 and niclosamide prevents proliferation and growth of treatment-na\u00efve and vemurafenib-resistant melanomas","volume":"9","author":"Figarola","year":"2018"},{"key":"10.1016\/j.ejmech.2025.117527_bib145","volume":"vol. 21","author":"Zheng","year":"2022"},{"key":"10.1016\/j.ejmech.2025.117527_bib146","first-page":"119","volume":"vol. 180","author":"Shah","year":"2022"},{"issue":"13","key":"10.1016\/j.ejmech.2025.117527_bib147","first-page":"1618","article-title":"Nanoliposomal encapsulation enhances in vivo anti-tumor activity of niclosamide against melanoma","volume":"19","author":"Hatamipour","year":"2019"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117527_bib148","first-page":"549","article-title":"Niclosamide inhibits the cell proliferation and enhances the responsiveness of esophageal cancer cells to chemotherapeutic agents","volume":"43","author":"Lee","year":"2020"},{"issue":"9","key":"10.1016\/j.ejmech.2025.117527_bib149","article-title":"Niclosamide induces protein ubiquitination and inhibits multiple pro-survival signaling pathways in the human glioblastoma U-87 MG cell line","volume":"12","author":"Cheng","year":"2017"},{"issue":"15","key":"10.1016\/j.ejmech.2025.117527_bib150","first-page":"4124","article-title":"Anticancer effects of niclosamide in human glioblastoma","volume":"19","author":"Wieland","year":"2013"},{"key":"10.1016\/j.ejmech.2025.117527_bib151","first-page":"2817","article-title":"Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres","volume":"146","author":"Oh","year":"2020"},{"issue":"8","key":"10.1016\/j.ejmech.2025.117527_bib152","first-page":"1521","volume":"16","author":"Liu","year":"2017","journal-title":"Niclosamide and bicalutamide combination treatment overcomes enzalutamide-and bicalutamide-resistant prostate cancer"},{"issue":"6","key":"10.1016\/j.ejmech.2025.117527_bib153","article-title":"A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer","volume":"13","author":"Schweizer","year":"2018"},{"issue":"22","key":"10.1016\/j.ejmech.2025.117527_bib154","volume":"7","author":"Liu","year":"2016","journal-title":"Niclosamide enhances abiraterone treatment via inhibition of androgen receptor variants in castration resistant prostate cancer"},{"issue":"13","key":"10.1016\/j.ejmech.2025.117527_bib155","first-page":"1341","article-title":"Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3\u2010AR axis inhibition","volume":"75","author":"Liu","year":"2015"},{"issue":"6","key":"10.1016\/j.ejmech.2025.117527_bib156","first-page":"2944","article-title":"Niclosamide exerts anticancer effects through inhibition of the FOXM1-mediated DNA damage response in prostate cancer","volume":"11","author":"Kim","year":"2021"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117527_bib157","article-title":"A novel high content imaging-based screen identifies the anti-helminthic niclosamide as an inhibitor of lysosome anterograde trafficking and prostate cancer cell invasion","volume":"11","author":"Circu","year":"2016"},{"key":"10.1016\/j.ejmech.2025.117527_bib158","first-page":"1","article-title":"Niclosamide suppresses renal cell carcinoma by inhibiting Wnt\/\u03b2-catenin and inducing mitochondrial dysfunctions","volume":"5","author":"Zhao","year":"2016"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117527_bib159","first-page":"827","article-title":"Niclosamide acts as a new inhibitor of vasculogenic mimicry in oral cancer through upregulation of miR-124 and downregulation of STAT3","volume":"39","author":"Li","year":"2018"},{"issue":"14","key":"10.1016\/j.ejmech.2025.117527_bib160","first-page":"3458","article-title":"Identification of niclosamide as a novel anticancer agent for adrenocortical carcinoma","volume":"22","author":"Satoh","year":"2016"},{"key":"10.1016\/j.ejmech.2025.117527_bib161","article-title":"Niclosamide causes lysosome-dependent cell death in endometrial cancer cells and tumors","volume":"161","author":"Rai","year":"2023"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117527_bib162","first-page":"165","volume":"35","author":"Wei","year":"2021","journal-title":"Targeting Wnt\/\u03b2\u2010catenin by anthelmintic drug niclosamide overcomes paclitaxel resistance in esophageal cancer"},{"key":"10.1016\/j.ejmech.2025.117527_bib163","first-page":"434","volume":"vol. 96","author":"Li","year":"2017"},{"issue":"9","key":"10.1016\/j.ejmech.2025.117527_bib164","article-title":"Inhibition of STAT3 by niclosamide synergizes with erlotinib against head and neck cancer","volume":"8","author":"Li","year":"2013"},{"key":"10.1016\/j.ejmech.2025.117527_bib165","first-page":"1544","volume":"vol. 9","author":"Han","year":"2019"},{"key":"10.1016\/j.ejmech.2025.117527_bib166","first-page":"403","article-title":"Niclosamide induces apoptosis through mitochondrial intrinsic pathway and inhibits migration and invasion in human thyroid cancer in vitro","volume":"92","author":"Yu","year":"2017"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117527_bib167","first-page":"416","article-title":"Anthelminthic drug niclosamide sensitizes the responsiveness of cervical cancer cells to paclitaxel via oxidative stress-mediated mTOR inhibition","volume":"484","author":"Chen","year":"2017"},{"issue":"13","key":"10.1016\/j.ejmech.2025.117527_bib168","first-page":"3105","article-title":"Repurposing niclosamide for targeting pancreatic cancer by inhibiting hh\/gli non-canonical axis of gsk3\u03b2","volume":"13","author":"Kaushal","year":"2021"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117527_bib169","first-page":"112","article-title":"The anthelmintic drug niclosamide induces GSK-\u03b2-mediated \u03b2-catenin degradation to potentiate gemcitabine activity, reduce immune evasion ability and suppress pancreatic cancer progression","volume":"13","author":"Guo","year":"2022"},{"issue":"19","key":"10.1016\/j.ejmech.2025.117527_bib170","first-page":"5399","volume":"5","author":"Sedky","year":"2023","journal-title":"Box\u2013Behnken design of thermo-responsive nano-liposomes loaded with a platinum (IV) anticancer complex: evaluation of cytotoxicity and apoptotic pathways in triple negative breast cancer cells"},{"issue":"8","key":"10.1016\/j.ejmech.2025.117527_bib171","first-page":"726","article-title":"The anthelmintic drug niclosamide inhibits the proliferative activity of human osteosarcoma cells by targeting multiple signal pathways","volume":"15","author":"Liao","year":"2015"},{"issue":"4","key":"10.1016\/j.ejmech.2025.117527_bib172","first-page":"1763","article-title":"Niclosamide inhibits the proliferation of human osteosarcoma cell lines by inducing apoptosis and cell cycle arrest","volume":"33","author":"Li","year":"2015"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117527_bib173","first-page":"484","article-title":"Niclosamide suppresses migration and invasion of human osteosarcoma cells by repressing TGFBI expression via the ERK signaling pathway","volume":"23","author":"Yeh","year":"2022"},{"issue":"22","key":"10.1016\/j.ejmech.2025.117527_bib174","first-page":"4150","article-title":"Niclosamide inhibits cell growth and enhances drug sensitivity of hepatocellular carcinoma cells via STAT3 signaling pathway","volume":"9","author":"Wang","year":"2018"},{"key":"10.1016\/j.ejmech.2025.117527_bib175","first-page":"1","volume":"vol. 16","author":"Weng","year":"2016"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117527_bib176","first-page":"30","article-title":"Niclosamide suppresses T-cell acute lymphoblastic leukemia growth through activation of apoptosis and autophagy","volume":"47","author":"Huang","year":"2022"},{"issue":"4","key":"10.1016\/j.ejmech.2025.117527_bib177","first-page":"4301","article-title":"Niclosamide suppresses acute myeloid leukemia cell proliferation through inhibition of CREB-dependent signaling pathways","volume":"9","author":"Chae","year":"2018"},{"key":"10.1016\/j.ejmech.2025.117527_bib178","first-page":"27","volume":"vol. 9","author":"Zhang","year":"2019"},{"issue":"12","key":"10.1016\/j.ejmech.2025.117527_bib179","first-page":"3312","article-title":"Niclosamide as a repurposing drug against Gram-positive bacterial infections","volume":"77","author":"Zhang","year":"2022"},{"key":"10.1016\/j.ejmech.2025.117527_bib180","volume":"vol. 140","author":"Pindiprolu","year":"2020"},{"issue":"15","key":"10.1016\/j.ejmech.2025.117527_bib181","article-title":"Niclosamide repurposed for the treatment of inflammatory airway disease","volume":"4","author":"Cabrita","year":"2019"},{"issue":"7","key":"10.1016\/j.ejmech.2025.117527_bib182","first-page":"2032","article-title":"Niclosamide attenuates inflammation-associated profibrotic responses in human subepithelial lung myofibroblasts","volume":"11","author":"Spathakis","year":"2023"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117527_bib183","first-page":"398","article-title":"Endometriotic inflammatory microenvironment induced by macrophages can be targeted by niclosamide","volume":"100","author":"Sekulovski","year":"2019"},{"issue":"5","key":"10.1016\/j.ejmech.2025.117527_bib184","article-title":"Efficacy of niclosamide on the intra-abdominal inflammatory environment in endometriosis","volume":"35","author":"Shi","year":"2021"},{"issue":"12","key":"10.1016\/j.ejmech.2025.117527_bib185","first-page":"1023","article-title":"Niclosamide inhibits the inflammatory and angiogenic activation of human umbilical vein endothelial cells","volume":"64","author":"Huang","year":"2015"},{"key":"10.1016\/j.ejmech.2025.117527_bib186","first-page":"225","volume":"vol. 64","author":"Liang","year":"2015"},{"issue":"4","key":"10.1016\/j.ejmech.2025.117527_bib187","first-page":"426","article-title":"The anti-rheumatoid activity of niclosamide in collagen-induced arthritis in rats","volume":"34","author":"Ali","year":"2019"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117527_bib188","first-page":"1810","volume":"16","author":"Zhang","year":"2017","journal-title":"Niclosamide attenuates inflammatory cytokines via the autophagy pathway leading to improved outcomes in renal ischemia\/reperfusion injury"},{"issue":"6","key":"10.1016\/j.ejmech.2025.117527_bib189","first-page":"5270","article-title":"Repurposing an old drug for new use: niclosamide in psoriasis\u2010like skin inflammation","volume":"235","author":"Thatikonda","year":"2020"},{"key":"10.1016\/j.ejmech.2025.117527_bib190","series-title":"Niclosamide Modulates Phenotypic Switch and Inflammatory Responses in Human Pulmonary Arterial Smooth Muscle Cells","first-page":"1","author":"Lu","year":"2024"},{"key":"10.1016\/j.ejmech.2025.117527_bib191","series-title":"Dual-Ligand-Modified Nanoscale Liposomes Co-encapsulating Aspirin and Curcumin Inhibit Platelet-Induced Tumor Proliferation and Metastasis","author":"Liu","year":"2024"},{"issue":"3","key":"10.1016\/j.ejmech.2025.117527_bib192","article-title":"Neuroprotective effects of niclosamide on disease progression via inflammatory pathways modulation in SOD1-G93A and FUS-associated amyotrophic lateral sclerosis models","volume":"21","author":"Milani","year":"2024"},{"issue":"10","key":"10.1016\/j.ejmech.2025.117527_bib193","first-page":"1261","article-title":"The S100A4 transcriptional inhibitor niclosamide reduces pro-inflammatory and migratory phenotypes of microglia: implications for amyotrophic lateral sclerosis","volume":"8","author":"Serrano","year":"2019"},{"issue":"8","key":"10.1016\/j.ejmech.2025.117527_bib194","first-page":"3018","article-title":"Niclosamide prevents systemic sclerosis in a reactive oxygen species\u2013induced mouse model","volume":"197","author":"Morin","year":"2016"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117527_bib195","first-page":"343","article-title":"Niclosamide suppresses RANKL-induced osteoclastogenesis and prevents LPS-induced bone loss","volume":"470","author":"Cheon","year":"2016"},{"issue":"5","key":"10.1016\/j.ejmech.2025.117527_bib196","first-page":"909","article-title":"Broad spectrum antiviral agent niclosamide and its therapeutic potential","volume":"6","author":"Xu","year":"2020"},{"key":"10.1016\/j.ejmech.2025.117527_bib197","volume":"vol. 197","author":"Li","year":"2022"},{"issue":"8","key":"10.1016\/j.ejmech.2025.117527_bib198","article-title":"The antiparasitic drug niclosamide inhibits dengue virus infection by interfering with endosomal acidification independent of mTOR","volume":"12","author":"Kao","year":"2018"},{"issue":"6","key":"10.1016\/j.ejmech.2025.117527_bib199","article-title":"Inhibition of human immunodeficiency virus type 1 by niclosamide through mTORC1 inhibition","volume":"6","author":"Niyomdecha","year":"2020"},{"issue":"10","key":"10.1016\/j.ejmech.2025.117527_bib200","article-title":"Niclosamide is a proton carrier and targets acidic endosomes with broad antiviral effects","volume":"8","author":"Jurgeit","year":"2012"},{"key":"10.1016\/j.ejmech.2025.117527_bib201","first-page":"68","volume":"vol. 138","author":"Huang","year":"2017"},{"key":"10.1016\/j.ejmech.2025.117527_bib202","volume":"vol. 295","author":"Niyomdecha","year":"2021"},{"key":"10.1016\/j.ejmech.2025.117527_bib203","first-page":"81","volume":"vol. 135","author":"Wang","year":"2016"},{"issue":"12","key":"10.1016\/j.ejmech.2025.117527_bib204","volume":"16","author":"Weiss","year":"2021","journal-title":"Niclosamide shows strong antiviral activity in a human airway model of SARS-CoV-2 infection and a conserved potency against the Alpha (B. 1.1. 7), Beta (B. 1.351) and Delta variant (B. 1.617. 2)"},{"key":"10.1016\/j.ejmech.2025.117527_bib205","volume":"vol. 40","author":"Shamim","year":"2021"},{"issue":"5","key":"10.1016\/j.ejmech.2025.117527_bib206","first-page":"651","article-title":"Niclosamide as a repurposing drug against Corynebacterium striatum multidrug-resistant infections","volume":"11","author":"Folliero","year":"2022"},{"issue":"6","key":"10.1016\/j.ejmech.2025.117527_bib207","first-page":"897","article-title":"Repurposing niclosamide for intestinal decolonization of vancomycin-resistant enterococci","volume":"51","author":"Mohammad","year":"2018"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117527_bib208","first-page":"3701","article-title":"Repurposing the anthelmintic drug niclosamide to combat Helicobacter pylori","volume":"8","author":"Tharmalingam","year":"2018"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117527_bib209","first-page":"5233","article-title":"Host-targeted niclosamide inhibits C. difficile virulence and prevents disease in mice without disrupting the gut microbiota","volume":"9","author":"Tam","year":"2018"},{"issue":"5","key":"10.1016\/j.ejmech.2025.117527_bib210","first-page":"e790","article-title":"Topical niclosamide (ATx201) reduces Staphylococcus aureus colonization and increases shannon diversity of the skin microbiome in atopic dermatitis patients in a randomized, double\u2010blind, placebo\u2010controlled phase 2 trial","volume":"12","author":"Weiss","year":"2022"},{"issue":"13","key":"10.1016\/j.ejmech.2025.117527_bib211","first-page":"4005","article-title":"Niclosamide is active in vitro against mycetoma pathogens","volume":"26","author":"Mahmoud","year":"2021"},{"key":"10.1016\/j.ejmech.2025.117527_bib212","series-title":"Strains with Distinct Genetic and Antifungal Susceptibility Backgrounds","first-page":"1","article-title":"In vitro activity of the anthelmintic drug niclosamide against Sporothrix spp","author":"Ramos","year":"2024"},{"issue":"8","key":"10.1016\/j.ejmech.2025.117527_bib213","article-title":"Niclosamide-loaded nanoparticles disrupt Candida biofilms and protect mice from mucosal candidiasis","volume":"20","author":"Sutar","year":"2022"},{"issue":"11","key":"10.1016\/j.ejmech.2025.117527_bib214","first-page":"5977","article-title":"The antifungal potential of niclosamide and structurally related salicylanilides","volume":"25","author":"Biersack","year":"2024"},{"issue":"11","key":"10.1016\/j.ejmech.2025.117527_bib215","first-page":"e2550","article-title":"Global burden of human mycetoma: a systematic review and meta-analysis","volume":"7","author":"van de Sande","year":"2013"},{"issue":"3","key":"10.1016\/j.ejmech.2025.117527_bib216","first-page":"170","article-title":"Recent taxonomic developments with Candida and other opportunistic yeasts","volume":"6","author":"Brandt","year":"2012"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117527_bib217","first-page":"129","article-title":"Candida auris in Austria\u2014what is new and what is different","volume":"9","author":"Spettel","year":"2023"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117527_bib218","article-title":"A phenotypic small-molecule screen identifies halogenated salicylanilides as inhibitors of fungal morphogenesis, biofilm formation and host cell invasion","volume":"8","author":"Garcia","year":"2018"},{"key":"10.1016\/j.ejmech.2025.117527_bib219","volume":"vol. 116","author":"Almeida-Paes","year":"2021"},{"issue":"9","key":"10.1016\/j.ejmech.2025.117527_bib220","first-page":"1171","article-title":"Development and application of a high-throughput screening method to evaluate antifungal activity against trichophyton tonsurans","volume":"20","author":"Preuett","year":"2015"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425002922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425002922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:23:22Z","timestamp":1745454202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425002922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":220,"alternative-id":["S0223523425002922"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117527","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological advances and therapeutic applications of niclosamide in cancer and other diseases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117527","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117527"}}